volociximab MeSH Supplementary Concept Data 2025

Details
Concepts

MeSH Supplementary: volociximab
Unique ID: C516631
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C516631
Entry Term(s): M-200; M200
Pharm Action: Angiogenesis Inhibitors
Registry Numbers: 496K5Z02NW
Heading Mapped to: *Antibodies, Monoclonal
Frequency: 13
Note: an anti-alpha5beta1 integrin antibody as anti-angiogenic agent
Source: J Exp Ther Oncol 2006;5(4):273-86
Date of Entry: 2007/01/31
Revision Date: 2019/11/01

volociximab Preferred

M-200 Narrower

page delivered in 0.004s